|
EP0076841A4
(en)
*
|
1981-04-17 |
1984-01-16 |
American Hospital Supply Corp |
IMPROVED SOLUTION FOR PARENTERAL NUTRITION.
|
|
FR2508797B1
(fr)
*
|
1981-07-03 |
1986-03-14 |
Charles Chany |
Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
|
|
DE3329253A1
(de)
*
|
1983-08-12 |
1985-02-21 |
Milupa Ag, 6382 Friedrichsdorf |
Verwendung eines aminosaeuregemisches zur bekaempfung insbesondere von lymphadenomen
|
|
HU191598B
(en)
*
|
1984-03-20 |
1987-03-30 |
Egyt Gyogyszervegyeszeti Gyar |
Method for the preparation of injection solution suitable preferably against cathosis
|
|
DE3440090A1
(de)
*
|
1984-11-02 |
1986-05-07 |
Novo-Med AG, Appenzell |
Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
|
|
IL77629A
(en)
*
|
1985-01-22 |
1989-07-31 |
Abbott Lab |
High fat,low carbohydrate enteral nutritional for mula
|
|
FR2591893B1
(fr)
*
|
1985-12-19 |
1988-11-10 |
Centre Nat Rech Scient |
Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
|
|
US5162373A
(en)
*
|
1986-01-17 |
1992-11-10 |
Board Of Regents, The University Of Texas System |
Methods and improved formulations for the determination and treatment of malignant disease in patients
|
|
US5189025A
(en)
*
|
1988-12-09 |
1993-02-23 |
Board Of Regenets, The University Of Texas System |
Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
|
|
GB8917660D0
(en)
*
|
1989-08-02 |
1989-09-20 |
Rana Ashok S J |
Prophylaxis of transurethral resection reactions
|
|
US5658895A
(en)
*
|
1991-10-07 |
1997-08-19 |
Otsuka Pharmaceutical Factory, Inc. |
Anticancer enteral feeding composition
|
|
KR0172193B1
(ko)
*
|
1991-10-07 |
1999-02-01 |
오오쓰까 아끼히꼬 |
암 치료용 경장제제
|
|
DE4228897A1
(de)
*
|
1992-08-29 |
1994-03-03 |
Wella Ag |
Mittel zur Festigung der Haare auf der Basis von Lignin oder Ligninderivaten sowie Dihydroxypropyllignin
|
|
DE69332357T2
(de)
*
|
1992-11-19 |
2003-06-18 |
Anticancer Inc., San Diego |
Verwendung von methioninase als antitumormittel in der antimethionin-chemotherapie
|
|
HU213677B
(en)
*
|
1993-11-09 |
1997-12-29 |
Immunal Kft |
Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
|
|
RU2125874C1
(ru)
*
|
1994-07-04 |
1999-02-10 |
Казанский государственный университет им.В.И.Ульянова-Ленина |
Композиция аминокислот с микроэлементами, обладающая противоопухолевой и антигипоксической активностью
|
|
CA2260886A1
(en)
*
|
1996-07-30 |
1998-02-05 |
Novartis Nutrition Ag |
Amino acid composition and use thereof in treating tumor growth and metastasis
|
|
EP1068868A3
(en)
*
|
1997-07-08 |
2001-01-31 |
Rath, Matthias, Dr. med. |
Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
|
|
RU2144821C1
(ru)
*
|
1999-02-16 |
2000-01-27 |
Товарищество с ограниченной ответственностью Фирма "ГЛЕС" |
Противоопухолевое средство
|
|
DE60027415T2
(de)
*
|
2000-06-16 |
2006-10-19 |
Rath, Matthias, Dr.med. |
Zusammensetzung für die Verhinderung der Glattmuskelkrankheiten, die Ascorbat, Arginin und Magnesium enthält
|
|
PT1195159E
(pt)
*
|
2000-10-09 |
2006-08-31 |
Rath Matthias |
Combinacao terapeutica de ascorbato com lisina e arginina para prevencao e tratamento do cancro
|
|
CH694549A5
(de)
|
2001-01-16 |
2005-03-31 |
Dr Matthias Rath |
Verwendung einer synergistischen Zusammensetzung, die Ascorbat und Lysin für Zustände enthält zur Behandlung extrazellularer Matrixdegeration.
|
|
US6686340B2
(en)
|
2001-06-19 |
2004-02-03 |
Matthias Rath |
Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
|
|
SG106614A1
(en)
*
|
2001-06-21 |
2004-10-29 |
Matthias Rath Dr |
Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
|
|
JPWO2003030890A1
(ja)
*
|
2001-10-05 |
2005-02-10 |
哲朗 浅尾 |
免疫系活性化剤
|
|
US20030105104A1
(en)
*
|
2001-11-27 |
2003-06-05 |
Burzynski Stanislaw R. |
Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
|
|
US20050053664A1
(en)
|
2003-09-08 |
2005-03-10 |
Eliezer Zomer |
Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
|
|
EP1734819A1
(en)
*
|
2004-03-19 |
2006-12-27 |
Pro-Pharmaceuticals, Inc. |
Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
|
|
WO2007016952A1
(en)
*
|
2005-07-29 |
2007-02-15 |
Matuschka-Greiffenclau Markus |
Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
|
|
WO2007016949A1
(en)
*
|
2005-07-29 |
2007-02-15 |
Matuschka-Greiffenclau Markus |
Composition for reducing the risc of alcohol induced neuropathy
|
|
WO2007016951A1
(en)
*
|
2005-07-29 |
2007-02-15 |
Matuschka-Greiffenclau Markus |
Composition for reducing the risc of alcohol induced pancreatic cancer
|
|
WO2007016954A1
(en)
*
|
2005-07-29 |
2007-02-15 |
Matuschka-Greiffenclau Markus |
Composition for reducing drug or alcohol induced breast cancer risk
|
|
AU2006278823B2
(en)
|
2005-07-29 |
2011-05-12 |
Tima Foundation |
Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases
|
|
WO2007016950A1
(en)
*
|
2005-07-29 |
2007-02-15 |
Matuschka-Greiffenclau Markus |
Composition for reducing the risk of alcohol induced neurodegenerative disease
|
|
WO2007016953A1
(en)
*
|
2005-07-29 |
2007-02-15 |
Matuschka-Greiffenclau Markus |
Composition for reducing alcohol induced liver cancer risk
|
|
US8865646B2
(en)
|
2007-03-28 |
2014-10-21 |
University Of South California |
Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
|
|
ES2891733T3
(es)
|
2007-03-28 |
2022-01-31 |
Univ Southern California |
Inducción de la resistencia diferencial al estrés y usos de la misma
|
|
CA3045883C
(en)
*
|
2008-04-24 |
2022-06-28 |
University Of Southern California |
Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
|
|
JP6090836B2
(ja)
*
|
2011-02-17 |
2017-03-08 |
Ｅａファーマ株式会社 |
化学療法剤の抗腫瘍活性増強剤
|
|
JP2016117702A
(ja)
*
|
2014-12-22 |
2016-06-30 |
武輝 山田 |
ガン細胞の死滅法
|
|
JOP20190146A1
(ar)
|
2016-12-19 |
2019-06-18 |
Axcella Health Inc |
تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
|
|
CN111295187A
(zh)
|
2017-08-14 |
2020-06-16 |
胺细拉健康公司 |
用于治疗肝脏疾病的氨基酸组合物
|
|
MA52971A
(fr)
|
2018-06-20 |
2021-04-28 |
Axcella Health Inc |
Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
|
|
IT202000000454A1
(it)
*
|
2020-01-13 |
2021-07-13 |
Professional Dietetics Spa |
Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro
|
|
IT202000000442A1
(it)
|
2020-01-13 |
2021-07-13 |
Professional Dietetics Spa |
Composizioni comprendenti amino acidi per l'uso nella prevenzione e nel trattamento di effetti collaterali della chemioterapia
|